Ensysce Biosciences Stock (NASDAQ: ENSC) stock price, news, charts, stock research, profile.
Open | $0.560 |
Close | - |
Volume / Avg. | 21.815K / 805.352K |
Day Range | 0.555 - 0.573 |
52 Wk Range | 0.530 - 7.200 |
Market Cap | $4.415M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 27 |
Short Interest | 0.24% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ensysce Biosciences (NASDAQ: ENSC) through any online brokerage.
Other companies in Ensysce Biosciences’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Geovax Labs (NASDAQ:GOVX).
The latest price target for Ensysce Biosciences (NASDAQ: ENSC) was reported by HC Wainwright & Co. on Monday, September 25, 2023. The analyst firm set a price target for 7.00 expecting ENSC to rise to within 12 months (a possible 1142.02% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Ensysce Biosciences (NASDAQ: ENSC) is $0.5636 last updated Today at April 25, 2024 at 12:30 PM EDT.
There are no upcoming dividends for Ensysce Biosciences.
Ensysce Biosciences’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Ensysce Biosciences.
Ensysce Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.